Unlocking The Potential of CLINT1: A Protein Interaction Study

Target Name: CLINT1

NCBI ID: G9685

CLINT1

Unlocking The Potential of CLINT1: A Protein Interaction Study

CLINT1 (clusterin 1) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the clusterin family of transmembrane proteins, which are characterized by the presence of a cluster of Cytoplasmic stalk-like structures in the extracellular domain of the protein.

One of the unique features of CLINT1 is its ability to interact with other proteins and molecules. It has been shown to interact with a wide range of proteins, including members of the T-cell receptor complex, the PDGF receptor, and the G protein- coupled receptor. This interaction with other proteins has important implications for the function and regulation of CLINT1.

CLINT1 has also been shown to play a role in several cellular processes, including cell signaling, cell adhesion, and tissue organization. For example, CLINT1 has been shown to be involved in the regulation of T-cell development and function, and has been implicated in the development of certain types of cancer.

Despite its potential involvement in several cellular processes, CLINT1 is not well understood at the molecular level. The precise function of CLINT1 is not known, and there are limited studies that have been conducted to investigate its potential as a drug target or biomarker.

One potential avenue for studying the function of CLINT1 is its potential as a drug target. CLINT1 has been shown to interact with several proteins, including the T-cell receptor complex and the PDGF receptor. This suggests that it may be a potential target for small molecules that can modulate these interactions and alter the function of CLINT1.

Another potential avenue for studying the function of CLINT1 is its potential as a biomarker. CLINT1 has been shown to be expressed in several types of cancer, and may be a useful biomarker for the diagnosis and prognosis of certain types of cancer. Additionally, the regulation of CLINT1 expression may be a useful target for cancer therapies that aim to modulate cellular processes that are associated with cancer growth and progression.

In conclusion, CLINT1 is a protein that has been shown to interact with a wide range of proteins and molecules, and has been implicated in several cellular processes. Further research is needed to fully understand its function and potential as a drug target or biomarker.

Protein Name: Clathrin Interactor 1

Functions: Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). May have a role in transport via clathrin-coated vesicles from the trans-Golgi network to endosomes. Stimulates clathrin assembly

The "CLINT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLINT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets